Investment Stage

Focus Areas

About Investor

David Cruikshank is a Partner at ARCH Venture Partners, a firm that provides seed/early stage venture capital for technology firms in information technology, life sciences, and physical sciences. ARCH typically invests between $50K and $150.0M, focusing on Seed and Series A stages in Medical Devices, BioTech, and Semiconductors. David joined ARCH after obtaining an MBA from the University of Chicago and has been with the firm for 12 years, following a 10-year career divided between two semiconductor firms where he worked as an industrial engineer and business development manager.